Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine
2022 · Arthritis Research & Therapy · 49 citations
https://doi.org/10.1186/s13075-021-02674-w
E
Ennio Giulio Favalli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
259
Papers
6.0K
Citations
42
h-index
104
i10-index
Ennio Giulio Favalli is an academic researcher from University of Milan. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Systemic Lupus Erythematosus Research & Spondyloarthritis Studies and Treatments. The author has an h-index of 42, co-authored 221 publications.
ORCID: 0000-0003-1471-6467Papers by this author
worksBiologic discontinuation strategies and outcomes in patients with rheumatoid arthritis
2019 · Expert Review of Clinical Immunology · 16 citations
https://doi.org/10.1080/1744666x.2020.1686976
Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review
2022 · Rheumatology and Therapy · 7 citations
https://doi.org/10.1007/s40744-022-00486-1
Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulators
2025 · Pharmacological Research · 3 citations
https://doi.org/10.1016/j.phrs.2025.107714
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts
2018 · Autoimmunity Reviews · 2 citations
https://doi.org/10.1016/j.autrev.2018.07.002
Damage progression in rheumatoid arthritis: the role of biologic agents
2012 · Arthritis Research & Therapy · 0 citations
https://doi.org/10.1186/ar3716
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat